Feline panleukopenia virus (FPLV) is a significant causative agent of disease in both domestic cats and wild carnivores that poses a considerable threat to their health. Despite its clinical importance, the mechanisms underlying FPLV–host interactions remain poorly understood. In this study, we conducted a systematic analysis of transcriptomic changes in feline kidney cells (F81) infected with a Chinese FPLV strain using RNA-seq. The down-regulated differentially expressed genes (DEGs) were majorly enriched in the regulation of the cell cycle, cell growth, or cell senescence, while the up-regulated DEGs were found to be significantly associated with cellular pathways involved in cell cycle regulation, extrinsic apoptotic signaling, and key host immune responses, including Toll-like receptor, JAK-STAT, IL-17, and TNF signaling pathways. By validating the RNA-seq data with RT-qPCR (real-time quantitative PCR) results, we identified potentially important immune-associated genes involved in the host immune response to feline panleukopenia virus, including IGSF6, IFI44L, IFI6, IFITM10, IL1R1, and JAK3. Overall, our results provide valuable insights into the mechanisms underlying feline panleukopenia virus and its interactions with its host, laying the foundation for future research on this significant virus and its impact on feline health.
Pigeon circovirus (PiCV) is an important pathogen that infects pigeons, which can induce multiple disorders such as immunosuppression and respiratory symptoms, posing a serious threat to the pigeon industry. In this study, we combined the RAA and CRISPR/Cas12a assay to establish a highly sensitive and accurate detection method for PiCV. This detection method amplifies the target nucleic acids through RAA; and the resultant dsDNA is specifically recognized by crRNA, the trans-cleavage activity of Cas12a is activated, which further cleaves the fluorescent reporter group to generate a fluorescent signal that can be visually observed under blue light. The method established in this study exhibited high sensitivity, with a minimum detection limit of 6.08 copies/µL. It showed no cross-reactivity with non-PiCV samples, demonstrating high specificity. When 40 clinical samples were tested by this method and quantitative polymerase chain reaction (qPCR) respectively, the coincidence rate was 92.5%, and the method developed herein achieved a higher positive detection rate. In conclusion, we successfully developed a rapid, on-site operable, one-step visual detection method for PiCV, which holds promising application prospects.